In New Zealand, Medsafe is responsible for issuing Marketing Authorisations. Medsafe reviews all licence applications to ensure that the medical gases are safe for patient use, efficacious, covering all of the proposed indications and manufactured to the appropriate levels of quality. Where applicable, the medical gases (and their component gases) comply with the relevant European Pharmacopoeia monographs.
For more information on our medical gases and their corresponding authorisation numbers, please refer to the Medsafe products and applications database.